查詢結果分析
來源資料
相關文獻
- Peritoneal Function of Cirrhotic Patients on Long-Term Peritoneal Dialysis
- 肝硬化慢性尿毒病患連續腹膜透析治療之評估
- Pulmonary Function Changes in Cirrhotic Patients
- B型肝炎肝硬化合併高血壓性腎衰竭腹膜透析病例
- Peritoneal Dialysis in End-Stage Renal Disease Patients with Liver Cirrhosis and Ascites
- 腹膜透析在不同疾病的使用建議
- A Modified Fast Peritoneal Equilibration Test
- Recurrent Spontaneous Bacterial Empyema in Cirrhosis: A Case Report
- 肝硬化患者之細菌性感染--157位病例研究
- 腹膜透析併發再發性腹膜炎
頁籤選單縮合
題 名 | Peritoneal Function of Cirrhotic Patients on Long-Term Peritoneal Dialysis=肝硬化病人接受長期腹膜透析治療的腹膜功能 |
---|---|
作 者 | 劉炯勳; 鄭裕文; 高銘聰; | 書刊名 | 臺灣腎臟醫學會雜誌 |
卷 期 | 18:2 2004.05[民93.05] |
頁 次 | 頁67-70+92 |
分類號 | 415.534 |
關鍵詞 | 肝硬化; 腹膜透析; 腹膜平衡測試; Liver cirrhosis; PD; PET; |
語 文 | 英文(English) |
中文摘要 | 背景:接受腹膜透析的肝硬化病人,其腹膜的功能為何,仍然有相當多的爭議,這篇研究主要是探討肝硬化病人的腹膜功能和一般人有何差異性。方法:我們利用回溯性研究,從1998年1月1日到2002年12月31日共有10名在本院腹膜透析室接受腹膜透析合併肝硬化的病人,診斷肝硬化的標準是依據臨床、生化和超音波來診斷,並無組織學上的證據。我們另外在同一時期選取37名無肝硬化的病人當作控制組(平均年齡52.16±1.96歲)來比較他們的腹膜功能有何差異性。結果:肝硬化病人的4小時透析液和血清肌酸酐比值為0.83±0.19,控制組比值為0.62±0.09(p<0.001)。肝硬化病人的透析的血糖D/D0值為0.31±0.12,控制組0.41±0.08(p<0.005)。根據上述肝硬化病人的腹膜平衡測試結果,肝硬化病人傾向於高輸送的族群。結論:肝硬化病人的腹膜平衡測試傾向於高輸送的族群,這個結果是否跟這類病人的長期預後有關仍需要更多的研究與評估。 |
英文摘要 | Background: Results of peritoneal function of peritoneal dialysis (PD) in cirrhotic patients is still open to debate. The aim of this study was to evaluate the peritoneal function of PD in cirrhotic patients. Methods: Between January 1998 and December 2002, 10 patients with both liver cirrhosis and uremia who were undergoing CAPD therapy at our PD center were enrolled in this retrospective study. The diagnosis of liver cirrhosis was based on clinical, biochemical and ultrasound studies without there being any histological evidence. 37 patients without cirrhosis (mean age 52.16±1.96 year-old) who started PD therapy in the same period were enrolled in this study as the control group. Results: The 4 hour creatinine D/P of cirrhotic patients were 0.83±0.19 and 0.62±0.09 for the control group (p<0.001). The Glucose D/D0 of cirrhotic patients were 0.31±0.12 and 0.41±0.08 for the control patients (p<0.005). Based on above results, the peritoneal equilibrium tests of liver cirrhosis patients tended to belong to a high transporter category. Conclusions: The peritoneal equilibrium test in cirrhotic patients with PD was found to distribute to a high transporter group in this study. The question of whether the tendency of the transporter category in cirrhotic patients is linked to the long-term survival rate of PD treatment requires further specific and controlled investigation. |
本系統中英文摘要資訊取自各篇刊載內容。